Recent advances in tuberculosis research in India.
Tuberculosis (TB) continues to be the leading killer of mankind among all infectious diseases, especially in the developing countries. Since the discovery of tubercle bacillus more than 100 years ago, TB has been the subject of research in an attempt to develop tools and strategies to combat this disease. Research in Indian laboratories has contributed significantly towards developing the DOTS strategy employed worldwide in tuberculosis control programmes and elucidating the biological properties of its etiologic agent, M. tuberculosis. In recent times, the development of tools for manipulation of mycobacteria has given a boost to researchers working in this field. New strategies are being employed towards understanding the mechanisms of protection and pathogenesis of this disease. Molecular methods are being applied to develop new tools and reagents for prevention, diagnosis and treatment of tuberculosis. With the sequencing of the genome of M. tuberculosis, molecules are being identified for the development of new drugs and vaccines. In this chapter, the advances made in these areas by Indian researchers mainly during the last five years are reviewed.
Tyagi
Anil K
AK
Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, New Delhi-110021, India. AKT@dusc.ernet.in
Dhar
Neeraj
N
D006801:Humans; D007194:India; D009169:Mycobacterium tuberculosis / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity* / Q000502:physiology; D012106:Research / Q000639:trends*; D012107:Research Design; D014376:Tuberculosis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*